Lisicki Robert has filed 7 insider transactions across 2 companies since July 2023.
Most recent transaction: a grant/award of 1153000 shares of Zura Bio Ltd ($ZURA) on February 27, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2025 | Zura Bio Ltd | $ZURA | Lisicki Robert | Chief Executive Officer | A | Employee Share Option (Right to Buy) | 1153000 | $0.00 | 1,153,000.0000 | 75,070,761 | 9999.99% | 1.54% |
| Jan. 23, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | Lisicki Robert | Director | A | Stock Options | 20000 | $0.00 | 20,000.0000 | 1,219,550 | 9999.99% | 1.64% |
| Dec. 9, 2024 | Zura Bio Ltd | $ZURA | Lisicki Robert | Chief Executive Officer | A | Employee Share Option (Right to Buy) | 117000 | $0.00 | 117,000.0000 | 87,335,667 | 9999.99% | 0.13% |
| June 18, 2024 | Zura Bio Ltd | $ZURA | Lisicki Robert | Chief Executive Officer | A | Employee Share Option (Right to Buy) | 1050000 | $0.00 | 1,050,000.0000 | 46,914,542 | 9999.99% | 2.24% |
| Jan. 24, 2024 | Zura Bio Ltd | $ZURA | Lisicki Robert | See Remarks | A | Stock options | 1000000 | $0.00 | 1,000,000.0000 | 33,064,036 | 9999.99% | 3.02% |
| Jan. 18, 2024 | Cadrenal Therapeutics, Inc. | $CVKD | Lisicki Robert | Director | A | Stock Options | 50000 | $0.00 | 50,000.0000 | 899,465 | 9999.99% | 5.56% |
| July 23, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | Lisicki Robert | Director | A | Stock options | 75000 | $0.00 | 75,000.0000 | 11,722,754 | 9999.99% | 0.64% |